Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEARTO: HAI Raltitrexed and Oxaliplatin for Colorectal Liver Metastases
NCT01348412Phase 2Completed
- Sponsor
- Centre Georges-François Leclerc
- Start
- Dec 2010
- Primary completion
- Dec 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of raltitrexed and oxaliplatin in colorectal cancer (CRC) and liver metastases, sponsored by Centre Georges-François Leclerc. Started Dec 2010; status: completed.
02
Drugs
raltitrexedoxaliplatin
03
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT01348412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348412.